Paul Campbell
Comptroller/Controller/Auditor bei VIATRIS INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Paul B.
Campbell is currently the Chief Accounting Officer & Controller at Viatris, Inc. He previously worked at Mylan NV as the Chief Accounting Officer, Interim CFO & Senior VP.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VIATRIS, INC.
0,01% | 05.03.2024 | 154 144 ( 0,01% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Paul Campbell
| Unternehmen | Position | Beginn |
|---|---|---|
| VIATRIS INC. | Comptroller/Controller/Auditor | 16.11.2020 |
Ehemalige bekannte Positionen von Paul Campbell
| Unternehmen | Position | Ende |
|---|---|---|
Mylan NV
 Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Director of Finance/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VIATRIS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
